Gross Profit Margin (Quarterly) Chart

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2000. Start Trial.
Date Value
June 30, 2026 11.87%
March 31, 2026 5.87%
December 31, 2025 10.30%
September 30, 2025 4.58%
June 30, 2025 8.87%
March 31, 2025 7.35%
December 31, 2024 4.74%
September 30, 2024 4.35%
June 30, 2024 5.13%
March 31, 2024 4.65%
December 31, 2023 5.17%
September 30, 2023 6.78%
June 30, 2023 -3.64%
March 31, 2023 -10.03%
December 31, 2022 -3.77%
September 30, 2022 1.83%
June 30, 2022 9.62%
March 31, 2022 -45.94%
December 31, 2021 29.33%
September 30, 2021 52.75%
June 30, 2021 62.22%
March 31, 2021 64.56%
December 31, 2020 54.62%
September 30, 2020 42.22%
June 30, 2020 23.12%
Date Value
March 31, 2020 12.99%
December 31, 2019 12.80%
September 30, 2019 11.55%
June 30, 2019 12.35%
March 31, 2019 13.91%
December 31, 2018 12.67%
September 30, 2018 11.99%
June 30, 2018 14.57%
March 31, 2018 13.03%
December 31, 2017 11.42%
September 30, 2017 12.65%
June 30, 2017 10.71%
March 31, 2017 11.53%
December 31, 2016 16.12%
September 30, 2016 10.59%
June 30, 2016 13.12%
March 31, 2016 16.34%
December 31, 2015 18.27%
September 30, 2015 16.42%
June 30, 2015 15.93%
March 31, 2015 16.32%
December 31, 2014 17.64%
September 30, 2014 14.71%
June 30, 2014 14.98%
March 31, 2014 15.58%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Enovis Corp. 54.51%
Edwards Lifesciences Corp. 78.09%
Intuitive Surgical, Inc. 68.35%
Kewaunee Scientific Corp. 29.61%
STAAR Surgical Co. 71.98%